Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 13

Results: 13

Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1638, doi. 10.1038/onc.2012.198
By:
- Sutendra, G;
- Dromparis, P;
- Kinnaird, A;
- Stenson, T H;
- Haromy, A;
- Parker, J M R;
- McMurtry, M S;
- Michelakis, E D
Publication type:
Article
Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1651, doi. 10.1038/onc.2012.190
By:
- Palumbo, T;
- Faucz, F R;
- Azevedo, M;
- Xekouki, P;
- Iliopoulos, D;
- Stratakis, C A
Publication type:
Article
The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1735, doi. 10.1038/onc.2012.189
By:
- Castillo-Lluva, S;
- Tan, C-T;
- Daugaard, M;
- Sorensen, P H B;
- Malliri, A
Publication type:
Article
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1616, doi. 10.1038/onc.2012.193
By:
- Kim, K;
- Jutooru, I;
- Chadalapaka, G;
- Johnson, G;
- Frank, J;
- Burghardt, R;
- Kim, S;
- Safe, S
Publication type:
Article
The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1714, doi. 10.1038/onc.2012.179
By:
- Skrypek, N;
- Duchêne, B;
- Hebbar, M;
- Leteurtre, E;
- van Seuningen, I;
- Jonckheere, N
Publication type:
Article
The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1660, doi. 10.1038/onc.2012.188
By:
- Liu, Z;
- Zanata, S M;
- Kim, J;
- Peterson, M A;
- Di Vizio, D;
- Chirieac, L R;
- Pyne, S;
- Agostini, M;
- Freeman, M R;
- Loda, M
Publication type:
Article
Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1724, doi. 10.1038/onc.2012.177
By:
- Xue, X;
- Gao, W;
- Sun, B;
- Xu, Y;
- Han, B;
- Wang, F;
- Zhang, Y;
- Sun, J;
- Wei, J;
- Lu, Z;
- Zhu, Y;
- Sato, Y;
- Sekido, Y;
- Miao, Y;
- Kondo, Y
Publication type:
Article
LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1682, doi. 10.1038/onc.2012.183
By:
- Fan, S;
- Niu, Y;
- Tan, N;
- Wu, Z;
- Wang, Y;
- You, H;
- Ke, R;
- Song, J;
- Shen, Q;
- Wang, W;
- Yao, G;
- Shu, H;
- Lin, H;
- Yao, M;
- Zhang, Z;
- Gu, J;
- Qin, W
Publication type:
Article
Genome-wide mechanisms of Smad binding.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1609, doi. 10.1038/onc.2012.191
By:
- Morikawa, M;
- Koinuma, D;
- Miyazono, K;
- Heldin, C-H
Publication type:
Article
The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1702, doi. 10.1038/onc.2012.180
By:
- Ye, Y;
- Tian, H;
- Lange, A R;
- Yearsley, K;
- Robertson, F M;
- Barsky, S H
Publication type:
Article
The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1691, doi. 10.1038/onc.2012.182
By:
- Das, C M;
- Taylor, P;
- Gireud, M;
- Singh, A;
- Lee, D;
- Fuller, G;
- Ji, L;
- Fangusaro, J;
- Rajaram, V;
- Goldman, S;
- Eberhart, C;
- Gopalakrishnan, V
Publication type:
Article
Cross-talk between phosphorylation and SUMOylation regulates transforming activities of an adenoviral oncoprotein.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1626, doi. 10.1038/onc.2012.187
By:
- Wimmer, P;
- Blanchette, P;
- Schreiner, S;
- Ching, W;
- Groitl, P;
- Berscheminski, J;
- Branton, P E;
- Will, H;
- Dobner, T
Publication type:
Article
BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia.
Published in:
Oncogene, 2013, v. 32, n. 13, p. 1670, doi. 10.1038/onc.2012.186
By:
- Kuroda, I;
- Inukai, T;
- Zhang, X;
- Kikuchi, J;
- Furukawa, Y;
- Nemoto, A;
- Akahane, K;
- Hirose, K;
- Honna-Oshiro, H;
- Goi, K;
- Kagami, K;
- Yagita, H;
- Tauchi, T;
- Maeda, Y;
- Sugita, K
Publication type:
Article